Ergoteles’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Ergoteles’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-878,359	Closed	-$34.6M	–	993
2023 Q2	$34.6M	Buy	+878,359	New	+$31M	1.66%	3
2022 Q4	–	Sell	-38,006	Closed	-$682K	–	2072
2022 Q3	$682K	Buy	+38,006	New	+$499K	0.02%	648
2022 Q1	–	Sell	-98,520	Closed	-$1.65M	–	1739
2021 Q4	$1.65M	Buy	+98,520	New	+$1.61M	0.06%	291
2021 Q1	–	Sell	-32,200	Closed	-$223K	–	1138
2020 Q4	$223K	Buy	+32,200	New	+$206K	0.01%	584

Ergoteles's ISEE Position: Q3 2023 in Review

Ergoteles sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 878,359 shares — an estimated $34.6M sold.

Ergoteles first reported a position in ISEE in Q4 2020 and held it in 4 quarters. The position peaked at $34.6M in Q2 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

Ergoteles reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Ergoteles sold 878,359 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $34.6M.
Ergoteles first reported a position in IVERIC bio, Inc. Common Stock in Q4 2020 and held it in 4 quarters.
Ergoteles's IVERIC bio, Inc. Common Stock position peaked at $34.6M in Q2 2023.
0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on Ergoteles's 13F filing for Q3 2023, filed 14 Nov 2023.